Educate your clients on risk of disease and protecting their pets

Canine Influenza Disease Posts

No items to show.

Loading…

Lyme Disease Posts

No items to show.

Loading…

Canine Diabetes Disease Posts

No items to show.

Loading…

Feline Diabetes Disease Posts

No items to show.

Loading…

Leptospirosis Disease Posts

No items to show.

Loading…

Canine Cough & Other Respiratory Disease Posts

No items to show.

Loading…

Parvovirus Disease Posts

No items to show.

Loading…

Heartworm Disease Posts

No items to show.

Loading…

Canine Otitis Externa Posts

No items to show.

Loading…

Social Media How-To Guide

A social media step-by-step guide to help you create and maintain your healthcare team’s social media channels, tap into the right audiences and see what content gets the best response.

Drive Your Business with the Right Message

Choose from any of the filters (Brand, Outbreak or Disease) and easily find content that educates clients about disease and outbreak risks, compelling them to protect their pets with the right Merck Animal Health products.

Canine Cough & Other Respiratory Diseases

A highly contagious respiratory disease among dogs.

READ

Canine Diabetes

A manageable disorder in dogs with the proper veterinary care and medication.

Read

Canine Influenza

Dogs have no natural immunity to this relatively new and highly contagious disease.

Read
Loading…

No items to show.

Loading…

*Bravecto kills fleas and prevents flea infestations for 12 weeks. Bravecto Chew and Bravecto Topical for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION:

Bravecto has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. Bravecto Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures. Bravecto Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.